Developer docs
API playgroundTry for free, no card

Search company profiles

OHSU Tech Transfer

Full company profile

uuid003l1d4

Namestring
OHSU Tech Transfer
Legal namestring
Oregon Health & Science University
Websiteurl
ohsu.edu
Company typeenum
Public
Founded yearint
1887
Descriptiontext

Oregon Health & Science University (OHSU) is Oregon's only academic health center, a public state agency founded in 1887 and headquartered in Portland with a 10,000+ employee workforce. It operates three integrated missions — healing, teaching, and discovering — across owned hospitals and clinics (OHSU Hospital, Doernbecher Children's Hospital, Knight Cancer Institute, Knight Cardiovascular Institute, Brain Institute, Casey Eye Institute), five schools (Medicine, Nursing, Dentistry, Public Health, Pharmacy), and research cores and shared resources including an FEI Titan Krios Cryo-TEM platform for structural biology. Clinical and educational services extend across the Portland metro area, statewide Oregon, and into Southwest Washington (Vancouver).

The institution's research portfolio spans cellular therapies (notably CAR-T programs for cancer and autoimmune conditions including myasthenia gravis, lupus, dermatomyositis, and multiple sclerosis), neuro-oncology (a nearly 30-year program under Edward Neuwelt, M.D. that produced FDA approval for ferumoxytol-based brain tumor imaging), cancer, cardiovascular medicine, neurology, dentistry, and public health. Technology transfer is operated through OHSU Innovates and the tech-transfer office (ohsu.edu/xd/research/techtransfer), which licenses discoveries, manages intellectual property, and launches companies out of institutional research. The OHSU Experts database, powered by Elsevier Pure and integrating Scopus and grant data with SciVal benchmarking, provides institution-wide research information management.

OHSU is a public state agency — not a venture-backed or publicly traded company — funded through a mix of state appropriations, federal research grants (including NIH consortia), clinical revenue, and philanthropy via the OHSU Foundation. Revenue and pricing for technology-transfer services are not publicly disclosed. There are no parent companies, subsidiaries in the traditional corporate sense, M&A activity, or external equity investors. Customer/beneficiary segments include healthcare patients, students and trainees, researchers and academics, and volunteers/community members. Geographic scope is regional (Pacific Northwest); no claim of global commercial footprint is asserted.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
10,001+
akta.pro rankint
HeadquartersPortland, United States
HQ citystring
Portland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
technology transfer services, intellectual property licensing, biomedical research commercialization, university tech transfer, innovation partnerships
Industry1 code
PRIMARYBPAHAMAF
IP Licensing, Transactions & Technology Transfer
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Patent Owners & Lessors6794
  • Services-Commercial Physical & Biological Research8731
Product category
Technology Transfer Services
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

OHSU Tech Transfer (operating as OHSU Innovates) is the technology transfer arm of Oregon Health & Science University. It conducts biomedical research, licenses intellectual property and discoveries arising from university research, and launches startup companies based on those discoveries. The office manages the full commercialization lifecycle from invention disclosure through patent prosecution to licensing and new venture formation, supported by OHSU's research cores, clinical trial infrastructure, and faculty expertise.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • First OHSU patient treated with CAR-T for myasthenia gravis showing durable response four years post-treatment
+2 more records
Product overview1 text field

Oregon Health & Science University operates as an academic medical center offering healthcare services, research programs, and educational offerings. The primary technology and research tools documented include the OHSU Experts research information management system (a web-based portal aggregating faculty publications, grants, and collaboration data from Elsevier Pure and Scopus), research news platforms covering clinical advances, and clinical research programs including cellular therapy trials. OHSU does not present a unified commercial product portfolio but rather institutional services spanning patient care across multiple specialties, research cores and shared resources, and educational programs across schools of medicine, nursing, dentistry, public health, and pharmacy.

Product and service5 records
1OHSU Innovates (Technology Transfer and Commercialization)
CategoryTechnology Transfer Services
Description

OHSU Innovates is the central office that licenses OHSU discoveries and intellectual property to industry partners and launches startup companies around those discoveries. It serves industry licensees, entrepreneurs, and investors seeking access to university-derived biomedical IP.

2CAR-T Cell Therapy Program
CategoryClinical Research Program
Description

Clinical research program using chimeric antigen receptor T-cell (CAR-T) therapy for cancer and autoimmune conditions such as myasthenia gravis, lupus, and dermatomyositis. Available to patients participating in clinical trials and licensable to industry partners.

3Neuro-Oncology Blood-Brain Barrier Program (Ferumoxytol Imaging)
CategoryClinical Research Program
Description

Research program developing novel applications for ferumoxytol (an iron-based anemia drug) to improve imaging of brain tumors, resulting in FDA approval. Developed by OHSU laboratories under Edward Neuwelt, M.D.

4OHSU Experts Database
CategoryResearch Information Tool
Description

Searchable research information management system aggregating faculty and researcher outputs including publications, grants, facilities, and collaboration networks, powered by Elsevier Pure with data pulled from Scopus and grant databases.

5OHSU Research News and Events
CategoryInformation Service
Description

A news and events platform covering OHSU research developments, including clinical trials, FDA approvals, and scientific discoveries, used to communicate commercialization opportunities to industry partners.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-10-15
Description

OHSU is part of the NIH's $37 million Stillbirth Research Consortium focused on reducing preventable stillbirths in the U.S., particularly addressing disparities among BIPOC communities.

2Elsevier (Pure/SciVal)
Strategic tierCoreTypeTechnology or Integration
Description

OHSU utilizes Elsevier's Pure platform for the OHSU Experts database, which aggregates publication data from Scopus and grant databases. SciVal benchmarking tool is used for research analytics and benchmarking of research performance globally.

ohsu.edu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Johns Hopkins University's tech transfer and commercialization arm. Directly comparable in operating model — university-based licensing, biomedical emphasis, and company launch activity.

TypeDirect peer
Description

Coordinates tech transfer and IP licensing across the University of California system. Compares to OHSU as a large public university tech transfer organization with heavy biomedical output.

TypeDirect peer
Description

Mayo Clinic's technology transfer and commercialization arm. A direct peer as a clinical-research organization's licensing operation with significant biomedical IP output.

TypeDirect peer
Description

University of Wisconsin's technology transfer and patent licensing organization. Compares as a university-affiliated IP holder actively licensing biomedical and life sciences IP.

TypeDirect peer
Description

Stanford's tech transfer office responsible for IP licensing and startup creation. A direct peer given its scale, university base, and biotech-heavy licensing portfolio.

TypeDirect peer
Description

Harvard University's central tech transfer and IP licensing office. Directly comparable as a large academic tech transfer operation licensing life science and biotech IP from a leading research university.

TypeRegional player
Description

University of Washington's tech transfer and innovation hub serving the Pacific Northwest. A regionally adjacent peer given geography and biomedical research overlap with OHSU.

TypeDirect peer
Description

Vanderbilt's tech transfer operation with strong biomedical and pharma licensing activity. Comparable given similar university-based IP licensing scope.

TypeOthers
Description

Industry association representing university tech transfer offices. Thematically related as the broader ecosystem organization for OHSU Tech Transfer and its direct peers.

TypeDirect peer
Description

UCSF's tech transfer office focused on health sciences and biotech IP. Directly comparable given its biomedical-only focus and licensing/startup creation mandate.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries10 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

OHSU Tech Transfer

Technology Transfer Servicesohsu.edu

What OHSU Tech Transfer does

Oregon Health & Science University (OHSU) is Oregon's only academic health center, a public state agency founded in 1887 and headquartered in Portland with a 10,000+ employee workforce. It operates three integrated missions — healing, teaching, and discovering — across owned hospitals and clinics (OHSU Hospital, Doernbecher Children's Hospital, Knight Cancer Institute, Knight Cardiovascular Institute, Brain Institute, Casey Eye Institute), five schools (Medicine, Nursing, Dentistry, Public Health, Pharmacy), and research cores and shared resources including an FEI Titan Krios Cryo-TEM platform for structural biology. Clinical and educational services extend across the Portland metro area, statewide Oregon, and into Southwest Washington (Vancouver).

The institution's research portfolio spans cellular therapies (notably CAR-T programs for cancer and autoimmune conditions including myasthenia gravis, lupus, dermatomyositis, and multiple sclerosis), neuro-oncology (a nearly 30-year program under Edward Neuwelt, M.D. that produced FDA approval for ferumoxytol-based brain tumor imaging), cancer, cardiovascular medicine, neurology, dentistry, and public health. Technology transfer is operated through OHSU Innovates and the tech-transfer office (ohsu.edu/xd/research/techtransfer), which licenses discoveries, manages intellectual property, and launches companies out of institutional research. The OHSU Experts database, powered by Elsevier Pure and integrating Scopus and grant data with SciVal benchmarking, provides institution-wide research information management.

OHSU is a public state agency — not a venture-backed or publicly traded company — funded through a mix of state appropriations, federal research grants (including NIH consortia), clinical revenue, and philanthropy via the OHSU Foundation. Revenue and pricing for technology-transfer services are not publicly disclosed. There are no parent companies, subsidiaries in the traditional corporate sense, M&A activity, or external equity investors. Customer/beneficiary segments include healthcare patients, students and trainees, researchers and academics, and volunteers/community members. Geographic scope is regional (Pacific Northwest); no claim of global commercial footprint is asserted.

OHSU Tech Transfer firmographics

Firmographics
Name
OHSU Tech Transfer
Legal name
Oregon Health & Science University
Website
https://ohsu.edu
Company type
Public
Founded year
1887
Operating status
Operating
Headcount range
10,001+ employees
Ownership category
akta.pro rank

OHSU Tech Transfer industry classification

Industry
Product category
Technology Transfer Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYBPAHAMAF
IP Licensing, Transactions & Technology Transfer

Keywords

  • Technology transfer services
  • Intellectual property licensing
  • Biomedical research commercialization
  • University tech transfer
  • Innovation partnerships

Where OHSU Tech Transfer is headquartered

Location

Headquarters

HQ city
Portland
HQ country
United States
HQ region
North America

Offices3 records

Markets served

OHSU Tech Transfer business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Distribution channels2 records

Marketing channels4 records

OHSU Tech Transfer product offering

Product offering

Core offering

OHSU Tech Transfer (operating as OHSU Innovates) is the technology transfer arm of Oregon Health & Science University. It conducts biomedical research, licenses intellectual property and discoveries arising from university research, and launches startup companies based on those discoveries. The office manages the full commercialization lifecycle from invention disclosure through patent prosecution to licensing and new venture formation, supported by OHSU's research cores, clinical trial infrastructure, and faculty expertise.

Product overview

Oregon Health & Science University operates as an academic medical center offering healthcare services, research programs, and educational offerings. The primary technology and research tools documented include the OHSU Experts research information management system (a web-based portal aggregating faculty publications, grants, and collaboration data from Elsevier Pure and Scopus), research news platforms covering clinical advances, and clinical research programs including cellular therapy trials. OHSU does not present a unified commercial product portfolio but rather institutional services spanning patient care across multiple specialties, research cores and shared resources, and educational programs across schools of medicine, nursing, dentistry, public health, and pharmacy.

Differentiator

Problem solved

Functional benefit

Products and services

  • OHSU Innovates (Technology Transfer and Commercialization) OHSU Innovates is the central office that licenses OHSU discoveries and intellectual property to industry partners and launches startup companies around those discoveries. It serves industry licensees, entrepreneurs, and investors seeking access to university-derived biomedical IP.
  • CAR-T Cell Therapy Program Clinical research program using chimeric antigen receptor T-cell (CAR-T) therapy for cancer and autoimmune conditions such as myasthenia gravis, lupus, and dermatomyositis. Available to patients participating in clinical trials and licensable to industry partners.
  • Neuro-Oncology Blood-Brain Barrier Program (Ferumoxytol Imaging) Research program developing novel applications for ferumoxytol (an iron-based anemia drug) to improve imaging of brain tumors, resulting in FDA approval. Developed by OHSU laboratories under Edward Neuwelt, M.D.
  • OHSU Experts Database Searchable research information management system aggregating faculty and researcher outputs including publications, grants, facilities, and collaboration networks, powered by Elsevier Pure with data pulled from Scopus and grant databases.
  • OHSU Research News and Events A news and events platform covering OHSU research developments, including clinical trials, FDA approvals, and scientific discoveries, used to communicate commercialization opportunities to industry partners.

Quantifiable outcome

  • First OHSU patient treated with CAR-T for myasthenia gravis showing durable response four years post-treatment
  • +2 more outcomes

Companies that use OHSU Tech Transfer

Customer profile

Segments4 records

Ideal customer profiles3 records

OHSU Tech Transfer technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

OHSU Tech Transfer partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major and core.

  • NIH Stillbirth Research ConsortiummajorStrategic or Co-development Partner · 15 October 2025OHSU is part of the NIH's $37 million Stillbirth Research Consortium focused on reducing preventable stillbirths in the U.S., particularly addressing disparities among BIPOC communities.
  • Elsevier (Pure/SciVal)coreTechnology or IntegrationOHSU utilizes Elsevier's Pure platform for the OHSU Experts database, which aggregates publication data from Scopus and grant databases. SciVal benchmarking tool is used for research analytics and benchmarking of research performance globally.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

OHSU Tech Transfer competitors and assessment

Company assessment

Direct peers

Regional players

  • University of Washington CoMotion: University of Washington's tech transfer and innovation hub serving the Pacific Northwest. A regionally adjacent peer given geography and biomedical research overlap with OHSU.

Others

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

OHSU Tech Transfer social profiles

Digital presence

OHSU Tech Transfer compliance and trust

Trust signal

Compliance2 records

OHSU Tech Transfer financial estimates

Financial estimate

Revenue estimate

Valuation estimate

OHSU Tech Transfer leadership team

Management profile

Number of profiles

OHSU Tech Transfer subsidiaries and ownership

Company hierarchy

Subsidiaries10 records

OHSU Tech Transfer funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

OHSU Tech Transfer M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OHSU Tech Transfer

What does OHSU Tech Transfer do?

OHSU Tech Transfer (operating as OHSU Innovates) is the technology transfer arm of Oregon Health & Science University. It conducts biomedical research, licenses intellectual property and discoveries arising from university research, and launches startup companies based on those discoveries. The office manages the full commercialization lifecycle from invention disclosure through patent prosecution to licensing and new venture formation, supported by OHSU's research cores, clinical trial infrastructure, and faculty expertise.

Is OHSU Tech Transfer a public or private company?

OHSU Tech Transfer is a public company. It is classified as state government owned and is currently operating.

When was OHSU Tech Transfer founded?

OHSU Tech Transfer was founded in 1887. It employs 10,001+ people.

Where is OHSU Tech Transfer based?

OHSU Tech Transfer is headquartered in Portland, United States, in the North America region.

Who are OHSU Tech Transfer's main competitors?

Direct peers on record are Johns Hopkins Technology Ventures (JHTV), University of California Technology Transfer (UCTT), Mayo Clinic Ventures, Wisconsin Alumni Research Foundation (WARF), Stanford Office of Technology Licensing (Stanford Technology Ventures), Harvard Office of Technology Development, Vanderbilt Center for Technology Transfer and Commercialization and UCSF Innovation Ventures. University of Washington CoMotion is listed as a regional player. AUTM (Association of University Technology Managers) is listed as an others.

Does OHSU Tech Transfer have an API?

No public API is recorded for OHSU Tech Transfer.

What industry is OHSU Tech Transfer in?

OHSU Tech Transfer's product category is Technology Transfer Services. Its primary akta.pro industry code is BPAHAMAF, IP Licensing, Transactions & Technology Transfer. Its NAICS code is 5417 and its SIC code is 6794.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals